Log in to save to my catalogue

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart fail...

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart fail...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_834f83a20d984fa98f808b4aaa9abc11

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis

About this item

Full title

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis

Publisher

England: John Wiley & Sons, Inc

Journal title

ESC Heart Failure, 2022-10, Vol.9 (5), p.3198-3209

Language

English

Formats

Publication information

Publisher

England: John Wiley & Sons, Inc

More information

Scope and Contents

Contents

Aims
The initial and dynamic levels of B‐type natriuretic peptide (BNP) and N‐terminal‐prohormone BNP (NT‐proBNP) are routinely used in clinical practice to identify patients with acute and chronic heart failure. In addition, BNP/NT‐proBNP levels might be useful for risk stratification in patients with and without heart failure. We performed a m...

Alternative Titles

Full title

Higher BNP/NT‐pro BNP levels stratify prognosis equally well in patients with and without heart failure: a meta‐analysis

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_834f83a20d984fa98f808b4aaa9abc11

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_834f83a20d984fa98f808b4aaa9abc11

Other Identifiers

ISSN

2055-5822

E-ISSN

2055-5822

DOI

10.1002/ehf2.14019

How to access this item